Markers of mRNA stabilization and degradation, and RNAi within astrocytoma GW bodies

Journal of Neuroscience Research

Volumn 85, Issue 16, 2007, Pages 3619-3631

  Moser, Joanna J ^a   Eystathioy, Theophany ^a   Chan, Edward K L ^b   Fritzler, Marvin J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Ago2; Dicer; GW182; mRNA granules; P bodies

Indexed keywords

ARGONAUTE 2 PROTEIN; DICER; MESSENGER RNA; PROTEIN; PROTEIN FMRP; PROTEIN HDCP; PROTEIN HNRNPA1; PROTEIN LSM4; PROTEIN SYNCRIP; PROTEIN XRN1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOMA; ASTROCYTOMA CELL; BIODEGRADATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MARKER GENE; MOLECULAR STABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; RNA TRANSPORT;

ANIMALS; ASTROCYTES; ASTROCYTOMA; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELLS, CULTURED; DEAD-BOX RNA HELICASES; DNA-BINDING PROTEINS; ENDORIBONUCLEASES; EXORIBONUCLEASES; FRAGILE X MENTAL RETARDATION PROTEIN; GENE EXPRESSION REGULATION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; INCLUSION BODIES; MACROMOLECULAR SUBSTANCES; MICE; MICE, INBRED C57BL; RIBONUCLEOPROTEINS, SMALL NUCLEAR; RNA INTERFERENCE; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 36849085496     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21439     Document Type: Article

References (61)

1. Anderson P, Kedersha N. 2006. RNA granules. J Cell Biol 172:803-808.
2. Andrei MA, Ingelfinger D, Heintzmann R, Achsel T, Rivera-Pomar R, Luhrmann R. 2005. A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies. RNA 11:717-727.
3. Aschrafi A, Cunningham BA, Edelman GM, Vanderklish PW. 2005. The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain. Proc Natl Acad Sci U S A 102:2180-2185.
4. Atasoy U, Watson J, Patel D, Keene JD. 1998. ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J Cell Sci 111:3145-3156.
5. Bannai H, Fukatsu K, Mizutani A, Natsume T, Iemura S, Ikegami T, Inouie T, Mikoshiba K. 2004. An RNA-interacting protein, SYNCRIP (heterogeneous nuclear ribonuclear protein Q1/NSAP1) is a component of mRNA granule transported with inositol 1,4,5-trisphosphate receptor type 1 mRNA in neuronal dendrites. J Biol Chem 279:53427-53434.
6. Barbee SA, Estes PS, Cziko AM, Hillebrand J, Luedeman RA, Coller JM, Johnson N, Howlett IC, Geng C, Ueda R, Brand AH, Newbury SF, Wilhelm JE, Levine RB, Nakamura A, Parker R, Ramaswami M. 2006. Staufen- and FMRP-containing neuronal RNPs are structurally and functionally related to somatic P bodies. Neuron 52:997-1009.
7. Bashkirov VI, Scherthan H, Solinger JA, Buerstedde JM, Heyer WD. 1997. A mouse cytoplasmic exoribonuclease (mXRN1p) with preference for G4 tetraplex substrates. J Cell Biol 136:761-773.
8. Behm-Ansmant I, Rehwinkel J, Doerks T, Stark A, Bork P, Izaurralde E. 2006. mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev 20:1885-1898.
9. Belanger G, Stocksley MA, Vandromme M, Schaeffer L, Furic L, DesGroseillers L, Jasmin BJ. 2003. Localization of the RNA-binding proteins Staufen1 and Staufen2 at the mammalian neuromuscular junction. J Neurochem 86:669-677.
10. Bloch DB, Gulick T, Bloch KD, Yang WH. 2006. Processing body autoantibodies reconsidered. RNA 12:707-709.
11. Brengues M, Teixeira D, Parker R. 2005. Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies. Science 310:486-489.
12. Brennan CM, Steitz JA. 2001. HuR and mRNA stability. Cell Mol Life Sci 58:266-277.
13. Chu CY, Rana TM. 2006. Translation repression m human cells by microRNA-induced gene silencing requires RCK/p54. PLoS Biol 4:e210.
14. Cougot N, Babajko S, Seraphin B. 2004. Cytoplasmic foci are sites of mRNA decay in human cells. J Cell Biol 165:31-40.
15. Ding L, Spencer A, Morita K, Han M. 2005. The developmental timing regulator AIN-1 interacts with miRISCs and may target the argonaute protein ALG-1 to cytoplasmic P bodies in C. elegans. Mol Cell 19:437-447.
16. Eulalio A, Behm-Ansmant I, Izaurralde E. 2007. P bodies: at the crossroads of posttranscriptional pathways. Nat Rev Mol Cell Biol 8:9-22.
17. Eystathioy T, Chan EKL, Tenenbaum SA, Keene JD, Griffith KJ, Fritzler MJ. 2002a. A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol Biol Cell 13:1338-1351.
18. Eystathioy T, Peebles C, Hamel JC, Vaughan JH, Chan EKL. 2002b. Autoantibody to hLSm4 and the hepatameric LSm complex in anti-Sm sera. Arthritis Rheum 46:726-734.
19. Eystathioy T, Jakymiw A, Chan EKL, Séraphin B, Cougot N, Fritzler MJ. 2003b. The GW182 protein co-localizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies. RNA 9:1171-1173.
20. Eystathioy T, Chan EKL, Mahler M, Luft LM, Fritzler ML, Fritzler MJ. 2003a. A panel of monoclonal antibodies to cytoplasmic GW bodies and the mRNA binding protein GW182. Hybridoma Hybridomics 22:79-86.
21. Fan XC, Steitz JA. 1998. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 17:3448-3460.
22. Fenger-Gron M, Fillman C, Norrild B, Lykke-Andersen J. 2005. Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol Cell 20:905-915.
23. Ikeda K, Satoh M, Pauley KM, Fritzler MJ, Reeves WH, Chan EK. 2006. Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody. J Immunol Methods 317:38-44.
24. Ingelfinger D, Arndt-Jovin DJ, Luhrmann R, Achsel T. 2002. The human LSm1-7 proteins colocalize with the mRNA-degradmg enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci. RNA 8:1489-1501.
25. Jakymiw A, Eystathioy T, Satoh M, Hamel JC, Fritzler MJ, Chan EKL. 2005. Disruption of GW bodies impairs mammalian mRNA interference. Nat Cell Biol 7:1167-1174.
26. Jakymiw A, Ikeda K, Fritzler MJ, Reeves WH, Satoh M, Chan EKL. 2006. Autoimmune targeting of key components of RNA interference. Arthritis Res Ther 8:R87.
27. Jakymiw A, Pauley K, Li S, Ikeda K, Lian S, Eystathioy T, Satoh M, Fritzler MJ, Chan EKL. 2007. The role of GW/P bodies in RNA processing and silencing. J Cell Sci 120:1317-1323.
28. Jin P, Zarnescu DC, Ceman S, Nakamoto M, Mowrey J, Jongens TA, Nelson DL, Moses K, Warren ST. 2004. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci 7:113-117.
29. Kanai Y, Dohmae N, Hirokawa N. 2004. Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 43:513-525.
30. Kedersha N, Stoecklin G, Ayodele M, Yacono P, Lykke-Andersen J, Fritzler MJ, Scheuner D, Kaufman RJ, Golan DE, Anderson P. 2005. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J Cell Biol 169:871-884.
31. Keene JD. 1999. Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc Natl Acad Sci U S A 96:14085-14090.
32. Kohrmann M, Luo M, Kaether C, DesGroseillers L, Dotti CG, Kiebler MA. 1999. Microtubule-dependent recruitment of Staufen-green fluorescent protein into large RNA-containing granules and subsequent dendritic transport in living hippocampal neurons. Mol Biol Cell 10:2945-2953.
33. Korzhevskii DE, Otellin VA, Grigor'ev IP. 2005. Glial fibrillary acidic protein in astrocytes in the human neocortex. Neurosci Behav Physiol 35:789-792.
34. Kshirsagar M, Parker R. 2004. Identification of Edc3p as an enhancer of mRNA decapping in Saccharomyces cerevisiae. Genetics 166:729-739.
35. Leung AK, Calabrese JM, Sharp PA. 2006. Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules. Proc Natl Acad Sci U S A 103:18125-18130.
36. Lian S, Jakymiw A, Eystathioy T, Hamel JC, Fritzler MJ, Chan EK. 2006. GW bodies, microRNAs and the cell cycle. Cancer Biol Ther 5:242-245.
37. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, Hannon GJ. 2004. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305:1437-1441.
38. Liu J, Rivas FV, Wohlschlegel J, Yates JR III, Parker R, Hannon GJ. 2005a. A role for the P-body component GW182 in microRNA function. Nat Cell Biol 7:1161-1166.
39. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R. 2005b. Micro-RNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat. Cell Biol 7:719-723.
40. Mazroui R, Huot ME, Tremblay S, Filion C, Labelle Y, Khandjian EW. 2002. Trapping of messenger RNA by fragile X mental retardation protein into cytoplasmic granules induces translation repression. Hum Mol Genet 11:3007-3017.
41. Meister G, Landthaler M, Peters L, Chen PY, Urlaub H, Luhrmann R, Tuschl T. 2005. Identification of novel argonaute-associated proteins. Curr Biol 15:2149-2155.
42. Nedergaard M, Ransom B, Goldman SA. 2003. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 26:523-530.
43. Newman EA. 2003. New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci 26:536-542.
44. Pauley KM, Eystathioy T, Jakymiw A, Hamel JC, Fritzler MJ, Chan EK. 2006. Formation of GW bodies is a consequence of microRNA genesis. EMBO Rep 7:904-910.
45. Peng SS, Chen CY, Xu N, Shyu AB. 1998. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 17:3461-3470.
46. Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, Basyuk E, Bertrand E, Filipowicz W. 2005. Inhibition of translational initiation by Let-7 microRNA in human cells. Science 309:1573-1576.
47. Rehwinkel J, Behm-Ansmant I, Gatfield D, Izaurralde E. 2005. A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing. RNA 11:1640-1647.
48. Roegiers F. 2003. Insights into mRNA transport in neurons. Proc Natl Acad Sci U S A 100:1465-1466.
49. Schipke CG, Kettenmann H. 2004. Astrocyte responses to neuronal activity. Glia 47:226-232.
50. Sen GL, Blau HM. 2005. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat Cell Biol 7:633-636.
51. Sheth U, Parker R. 2003. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 300:805-808.
52. Stoecklin G, Stubbs T, Kedersha N, Wax S, Rigby WF, Blackwell TK, Anderson P. 2004. MK2-induced tristetraprolin: 14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J 23:1313-1324.
53. Tai HC, Schuman EM. 2006. MicroRNA: microRNAs reach out into dendrites. Curr Biol 16:R121-R123.
54. Tang SJ, Meulemans D, Vazquez L, Colaco N, Schuman E. 2001. A role for a rat homolog of staufen in the transport of RNA to neuronal dendrites. Neuron 32:463-475.
55. Teixeira D, Sheth U, Valencia-Sanchez MA, Brengues M, Parker R. 2005. Processing bodies require RNA for assembly and contain non-translating mRNAs. RNA 11:371-382.
56. van Dijk E, Cougot N, Meyer S, Babajko S, Wahle E, Séraphin B. 2002. Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J 21:6915-6924.
57. Vasudevan S, Steitz JA. 2007. AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell 128:1105-1118.
58. Villacé P, Marión RM, Ortín J. 2004. The composition of Staufen-containing RNA granules from human cells indicates their role in the regulated transport and translation of messenger RNAs. Nucleic Acids Res 32:2411-2420.
59. Volterra A, Meldolesi J. 2005. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6:626-640.
60. Yang Z, Jakymiw A, Wood MR, Eystathioy T, Rubin RL, Fritzler MJ, Chan EK. 2004. GW182 is critical for the stability of GW bodies expressed during the cell cycle and cell proliferation. J Cell Sci 117:5567-5578.
61. Yu JH, Yang WH, Gulick T, Bloch KD, Bloch DB. 2005. Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body. RNA 11:1795-1802.